e-learning
resources
Virtual 2021
07.09.2021
Advances in asthma treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Real-world treatment patterns of newly diagnosed patients with asthma and/or COPD
A. Markus (Rotterdam, Netherlands), P. Rijnbeek (Rotterdam, Netherlands), J. Kors (Rotterdam, Netherlands), G. Brusselle (Ghent, Belgium), E. Burn (Oxford, United Kingdom), D. Prieto-Alhambra (Oxford, United Kingdom), K. Verhamme (Rotterdam, Netherlands)
Source:
Virtual Congress 2021 – Advances in asthma treatment
Session:
Advances in asthma treatment
Session type:
E-poster
Number:
3520
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Markus (Rotterdam, Netherlands), P. Rijnbeek (Rotterdam, Netherlands), J. Kors (Rotterdam, Netherlands), G. Brusselle (Ghent, Belgium), E. Burn (Oxford, United Kingdom), D. Prieto-Alhambra (Oxford, United Kingdom), K. Verhamme (Rotterdam, Netherlands). Real-world treatment patterns of newly diagnosed patients with asthma and/or COPD. 3520
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Characteristics and treatment patterns of newly diagnosed COPD patients in Canada
Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Year: 2019
Comparison of inhaler device preference of the physicians in the treatment of newly diagnosed adult asthma and COPD patients
Source: International Congress 2019 – Inhalers: adherence and preference
Year: 2019
Patterns of co-morbidities in newly diagnosed asthma
Source: Annual Congress 2010 - From diagnosis to disease management in primary care
Year: 2010
The clinical impact of long-acting bronchodilators in newly diagnosed COPD patients
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013
Patients at risk for COPD compared to patients diagnosed with COPD
Source: Annual Congress 2009 - Epidemiology of COPD
Year: 2009
COPD patients with asthma, characteristics and risk of exacerbations
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Severe outcomes of COVID-19 among patients with COPD and asthma
Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020
Year: 2021
Predictors of inhaled corticosteroid therapy in COPD alone compared to COPD with concomitant asthma managed in primary care
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Markers of T2-inflammation in patients with severe asthma and concomitant COPD
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020
The impact of using different symptom-based exacerbation definitions in COPD patients
Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation
Year: 2010
Differences between newly and previously diagnosed COPD patients in a spirometry program
Source: Annual Congress 2009 - Diagnostic strategies in primary respiratory care
Year: 2009
Real-world prescribing patterns among newly diagnosed COPD patients receiving ICS: An analysis of UK patient dataset
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
The prevalence and clinical characteristics of asthma–COPD overlap syndrome (ACOS) in patients with COPD
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017
Sexuality in patients with asthma and/or COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 54s
Year: 2003
Assessment of a disease management program for patients with asthma or COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 19s
Year: 2005
Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Life-sustaining treatment preferences of patients with severe COPD
Source: Annual Congress 2010 - Pulmonary rehabilitation and chronic care: new developments in interventions, assessment and care
Year: 2010
Antecedent hospitalization history of patients newly diagnosed with COPD
Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases
Year: 2020
Real-world treatment patterns of benralizumab therapy for patients with severe asthma
Source: Virtual Congress 2020 – Diagnosis and management of asthma
Year: 2020
Real-world medication use patterns in stable COPD patients from Romania
Source: International Congress 2019 – COPD treatment: cohorts and real-world studies
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept